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Abstract
Introduction The aetiology of lower respiratory tract infections
in young children admitted to the paediatric intensive care unit
(PICU) is often difficult to establish. However, most infections
are believed to be caused by respiratory viruses. A diagnostic
study was performed to compare conventional viral tests with
the recently developed real-time PCR technique.
Method Samples from children aged under 5 years presenting
to a tertiary PICU suspected of having a lower respiratory tract
infection were tested using conventional methods (viral culture
and immunofluorescence) and real-time PCR during the winter
season from December 2004 to May 2005. Conventional
methods were used to check for respiratory syncytial virus,
influenzavirus, parainfluenzavirus 1–3, rhinoviruses and
adenoviruses. Real-time PCR was used to test for respiratory
syncytial virus, influenzavirus, parainfluenzavirus 1–4,
rhinoviruses, adenoviruses, human coronaviruses OC43, NL63
and 229E, human metapneumovirus, Mycoplasma pneumoniae
and Chlamydia pneumoniae.
Results A total of 23 patients were included, of whom 11 (48%)
were positive for a respiratory virus by conventional methods.
Real-time PCR confirmed all of these positive results. In
addition, real-time PCR identified 22 more viruses in 11
patients, yielding a total of 22 (96%) patients with a positive
sample. More than one virus was detected in eight (35%)
children.
Conclusion Real-time PCR for respiratory viruses was found to
be a sensitive and reliable method in PICU patients with lower
respiratory tract infection, increasing the diagnostic yield
twofold compared to conventional methods.
Introduction
Lower respiratory tract infections (LRTIs) cause significant
hospitalization among children under 5 years old [1,2].
Although these infections are usually relatively mild, some chil-
dren develop respiratory failure, necessitating mechanical ven-
tilation and admission to the paediatric intensive care unit
(PICU). The aetiology of (severe) LRTI is often difficult to
establish. However, the majority of LRTIs in this young age
group is believed to be caused by respiratory viruses. For the
detection of respiratory viruses two conventional methods are
commonly used: viral culture and direct immunofluorescence
(DIF) assays. In addition, a third method based on molecular
techniques has now become available, namely (real-time)
PCR. Specifically, the real-time PCR format provides rapid
results, within a clinically relevant period of time. It allows
quantitative virus detection, and no post-PCR processing
needs to be performed. Moreover, compared with standard
format PCR, the risk for contamination is strongly reduced with
real-time PCR, rendering false-positive results with real-time
PCR highly unlikely [3].
Currently, there are no guidelines regarding which viral tests
are appropriate for young children with LRTI in the PICU [4].
Conventional detection methods have several disadvantages
DIF = direct immunofluorescence; hMPV = human metapneumovirus; LRTI = lower respiratory tract infection; PCR = polymerase chain reaction; PICU 
= paediatric intensive care unit; PIV = parainfluenzavirus; RSV = respiratory syncytial virus; RT = reverse transcriptase.Critical Care    Vol 10 No 2    van de Pol et al.
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compared with (real-time) PCR. Viral culture has been consid-
ered the gold standard for the detection of respiratory viruses,
but its limitation is that it can only detect a small number. Fur-
thermore, the yield of viral culture depends on the quality of
sampling, the correct transport and storage of samples, and
the type of cells used. In addition, the technique has a turna-
round time of several days to weeks, and is therefore unable to
guide initial patient management. The results of DIF assays are
available more rapidly, and this has been shown to improve
patient outcome with less antibiotic use and shorter hospital
stay [5-7]. Unfortunately, the DIF assay is less sensitive than
culture for the detection of certain pathogens.
PCR has been shown to be more sensitive than conventional
techniques and is fast [8-11]. Additional advantages of PCR
include its ability to identify multiple viruses simultaneously,
and to detect viral and atypical pathogens that cannot be cul-
tured or for which no DIF is commercially available (for exam-
ple, coronaviruses, human metapneumovirus [hMPV],
Chlamydia pneumoniae and  Mycoplasma pneumoniae).
Rapid and sensitive testing for a broad range of respiratory
viruses is vital in the PICU, and it can improve our understand-
ing of severe viral respiratory infections. Furthermore, it can be
used to guide cohorting strategies that may protect other crit-
ically ill children and to guide initial therapy. Finally, evaluation
of viral tests may be of future importance, when antiviral ther-
apy becomes more widely available.
In the present study conventional methods (viral culture and
DIF) were compared with real-time PCR for their ability to
detect respiratory viruses in young children with LRTI admitted
to the PICU. Secondary objectives were to describe the pres-
ence of viral pathogens and bacterial infection in LRTI patients
in the PICU.
Materials and methods
Study population
Children aged under 5 years admitted to the PICU of the Wil-
helmina Children's Hospital with LRTI were enrolled during
one winter season from December 2004 to May 2005. Wil-
helmina Children's Hospital is a tertiary university hospital with
a 14 bed PICU facility, and serves as a referral centre for the
central part of The Netherlands.
Patients were eligible if they had an admission diagnosis of
(probable) bronchiolitis, (probable) pneumonia, or respiratory
failure. Exclusion criteria were a primary cardiac or central ori-
gin of respiratory failure, and overt sepsis at the time of admis-
sion. The study described here was conducted as part of
normal patient care; therefore, according to the Medical Ethi-
cal Research Council of our institution, there was no need for
patient consent/ethical approval.
Samples
Sputa and/or nasopharyngeal aspirates were obtained from all
eligible patients for viral testing by viral culture, DIF and real-
time PCR assays. In addition, sputum and blood samples
(when available) were cultured and processed in accordance
with standard microbiological procedures. Sputum samples
were taken in a standardized manner, through sterile transtra-
cheal aspiration in intubated children.
Conventional virus detection
Some of the material obtained was used for immediate viral
culture of RSV, influenzaviruses, parainfluenzaviruses (PIVs)
1–3, picornaviruses, adenoviruses and herpesviruses on LLC-
MK2, RD, R-HELA and HEP-2C cells. Cultures were examined
twice weekly for the development of a cytopathological effect.
In positive cultures, virus was identified by immunofluores-
cence with monoclonal antibodies to RSV types A and B, influ-
enzaviruses A and B, PIV 1–3 and adenoviruses (DaKo,
Glostrup, Denmark). Rhinoviruses were identified using acid
lability tests.
Some of the material was subjected to DIF assays to detect
respiratory syncytial virus (RSV), influenzaviruses, PIV 1–3 and
adenoviruses using Imagen kits (DaKo), in accordance with
the manufacturer's recommended protocol. The remaining
material was used for real-time PCR testing.
Real-time PCR
Nucleic acids were extracted using the total nucleic acid pro-
tocol with the MagNA pure LC nucleic acid isolation system
(Roche Diagnostics, Basel, Switzerland). Each sample was
eluted in 200 µl buffer, which was sufficient for all real-time
PCR analyses. cDNA was synthesized by using MultiScribe
reverse transcriptase (RT) and random hexamers (both from
Applied Biosystems, Foster City, CA, USA). Each 200 µl reac-
tion mixture contained 80 µl of eluted RNA, 20 µl of 10 × RT
buffer, 5.5 mmol/l MgCl2, 500 µmol/l of each deoxynucleoside
triphosphate, 2.5 µmol/l random hexamer and 0.4 U of RNase
inhibitor per microlitre (all from Applied Biosystems). After
incubation for 10 minutes at 25°C, RT was carried out for 30
minutes at 48°C, followed by RT inactivation for 5 minutes at
95°C.
Detection of viral and atypical pathogens was performed in
parallel, using real-time PCR assays specific for the following:
RSV A and B, influenzavirus A and B, PIV 1–4, rhinoviruses,
adenoviruses, human coronavirus OC43, NL63 and 229E,
hMPV,  Mycoplasma pneumoniae and  Chlamydia pneumo-
niae. Real-time PCR procedures were performed as
described previously [12-14].
Briefly, samples were assayed in duplicate in a 25 µl reaction
mixture containing 10 µl (c)DNA, 12.5 µl 2 × TaqMan Univer-
sal PCR Master Mix (Applied Biosystems), 300–900 nmol/l of
the forward and reverse primers and 75–200 nmol/l of each ofAvailable online http://ccforum.com/content/10/2/R61
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the probes. All samples had been spiked before extraction
with an internal control virus (murine encephalomyocarditis
virus [RNA virus] and phocine herpes virus [DNA virus]) to
monitor for efficient extraction and amplification, essentially as
described previously [15].
Clinical data collection and analysis
Each patient's medical records were reviewed for clinical data.
Demographic data and the following clinical characteristics/
outcomes were extracted and entered into standardized
forms: gestational age, underlying disease, length of PICU
stay, need for mechanical ventilation and death. Five criteria
were used to classify the presence of bacterial infection at
admission or during the PICU stay: new infiltrate on the chest
radiograph, increased need for supplemental oxygen, fever
(temperature of 38.5°C or greater), increased infectious
parameters (C-reactive protein >40 mg/l and/or white blood
cell count >15 × 109/l) and positive bacterial culture (blood or
sputum). For the purpose of this study, 'no bacterial infection',
'possible bacterial infection' and 'proven bacterial infection'
were defined as the presence of fewer than two, two to three,
and more than three of the above criteria, respectively.
For the analysis of continuous variables, an unpaired t test was
used to compare means. Categorical variables were analyzed
using a two-tailed Fisher's exact test.
Results
Twenty-six PICU patients met the inclusion criteria. One
patient was admitted with a positive RSV test result from an
outside hospital, and no further testing was performed at our
institution. Another patient diagnosed with a bacterial pneu-
monia was subjected to no virus tests, and insufficient material
was obtained from a third patient to perform all respiratory
tests. Consequently, 23 patients were included in the subse-
quent analysis.
Table 1
Demographic and clinical characteristics of children with lower 
respiratory tract infection on admission to the PICU
Characteristic Value
Demographics
Age, median months (range) 2.6 (0.5–26.5)
Male 10 (43%)
Admissions from outside 
hospital
20 (87%)
Underlying conditions
Preterm birth (<37 weeks) 11 (48%)
Underlying disease 11 (48%)
Pulmonary 3
Cardiac 4
Other 5
Severity
ICU stay (days; median [range]) 10 (2–33)
Mechanically ventilated at PICU 20 (87%)
Deaths due to LRTI 1
A total of 23 patients were included in the study. LRTI, lower 
respiratory tract infection; PICU, paediatric intensive care unit.
Table 2
Viruses identified by conventional methods and real-time PCR
Pathogen Viral culture (n = 21) Immunofluorescence (n = 22) Real-time PCR (n = 23)
RSV A/B 4 7 16 (9)
Influenzavirus A/B 0 2 3 (1)
Rhinoviruses 0 6 (2)
Adenoviruses 2 2 3 (1)
Coronavirus OC43, 229E, NL63 3
hMPV 1 (1)
P I V  1 / 3 001
P I V  2 / 4 000
Chlamydia pneumoniae 0
Mycoplasma pneumoniae 0
Indeterminate 4
Total positive 6a 11a 33
Numbers in parentheses indicate single infections. aSingle infections. hMPV, human metapneumovirus; PCR, polymerase chain reaction; PIV, 
parainfluenzavirus; RSV, respiratory syncytial virus.Critical Care    Vol 10 No 2    van de Pol et al.
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The median age of the patients was 2.6 months, and the
majority were referred from an outside hospital (Table 1). The
PICU patients formed a heterogeneous group, with many
patients having underlying conditions resulting from preterm
birth or birth defects. Patients stayed in the PICU for a median
of 10 days; 20 (87%) patients needed mechanical ventilation.
Two patients in the study group died. One child suffered from
bronchiolitis with progressive bronchospasms, which in the
end could not be controlled. The second child had complex
underlying conditions; after eliminating all treatable causes
(including LRTI) the patient died from central hypoventilation.
Viral culture identified a respiratory virus in six PICU patients;
RSV and adenovirus were detected in four and two patients,
respectively (Table 2). The DIF assay appeared to be more
sensitive to detect respiratory viruses than viral culture in our
population, identifying a virus in 11 (48%) patients, including
the six patients diagnosed by viral culture.
Real-time PCR detected a total of 33 respiratory viruses in 22
(96%) patients. All positive results found by conventional tech-
niques were confirmed by real-time PCR. RSV was the single
most common respiratory virus found and was detected in 16
(70%) patients. In addition, rhinovirus was found in six (26%)
patients, and influenzavirus, adenovirus and coronavirus were
each detected in three (13%) children. PIV-3 and hMPV were
both found in one patient (4%). PIV-2 and PIV-4 and the atyp-
ical pathogens Mycoplasma pneumoniae and  Chlamydia
pneumoniae could not be detected in any of the LRTI patients.
In eight (35%) children more than one virus was detected. Six
children had a dual infection, one had a triple, and one had a
quadruple respiratory virus infection. RSV was detected in
seven of the eight children infected with multiple viruses,
including all three patients infected with a coronavirus. Of the
14 children with a single infection, nine had RSV. The other
five patients had an infection with rhinovirus (n = 2), influenza-
virus (n = 1), adenovirus (n = 1), or hMPV (n = 1).
No statistical differences were found between children with a
single and multiple virus infection with respect to age, sex,
gestational age, underlying disease, length of PICU stay,
mechanical ventilation and the presence of bacterial infection.
Bacterial cultures were performed in 14 patients. In eight
(57%) patients bacterial pathogens were identified (most
commonly Streptococcus pneumoniae, Moraxella catarrhalis,
Haemophilus influenzae and  Staphylococcus aureus). The
details for each patient regarding viral and bacterial infections,
including length of stay, are presented in Additional data file 1.
According to the predefined classification, six (26%) children
in the study group had proven, 11 (48%) had possible and six
(26%) had no bacterial infection. Of the six patients with a
proven bacterial infection, two infections developed after more
than 48 hours of mechanical ventilation. Overall, 19 (83%)
patients received antibiotics during their stay on the PICU for
a median of 7 days. Patients with a proven bacterial infection
stayed in the PICU for a mean of 18 days versus 9 days for
patients with possible or no bacterial infection (P = 0.026).
Discussion
In the present study conventional methods (viral culture and
DIF) were compared with real-time PCR for their ability to
detect respiratory viruses in young children admitted to the
PICU with LRTI. The use of real-time PCR increased the diag-
nostic yield from 48% to 96%, and all viruses found by con-
ventional methods were confirmed by real-time PCR. Whereas
with conventional methods no double infections were found,
real-time PCR revealed multiple virus infections in 35% of
patients.
The high diagnostic yield of PCR compared with conventional
techniques is in agreement with the findings of others. When
conducting a Medline search (1966 to September 2005) with
the search terms LRTI, PCR, and RSV or respiratory viruses,
we identified 11 hospital-based paediatric studies that com-
pared PCR with conventional techniques for more than two
respiratory viruses [8-11,16-22]. PCR was found to have
excellent sensitivity in all studies, if conventional methods were
considered the reference standard (0.91–1.00). In summary,
these studies showed that PCR increased the diagnostic yield
by by up to 25% as compared with conventional techniques.
However, most studies selected patients on the basis of res-
piratory test results, rather than selecting patients by admis-
sion diagnosis. Exceptions include the studies conducted by
Weinberg and coworkers [22] and Jennings and colleagues
[9]. Weinberg and coworkers [22] tested samples from 668
hospitalized children and selected patients on admission diag-
noses by the New Vaccine Surveillance Network. PCR assays
were used to test for RSV, influenzaviruses and PIV 1–3. With
viral culture 89 (13%) specimens were positive, as compared
with 185 (28%) positive specimens with PCR. Jennings and
colleagues [9] enrolled 75 hospitalized children using a case
definition of acute respiratory infection, and performed viral
diagnostics for a broad range of viruses. PCR identified 39
additional viruses, adding up to a total of 87 viruses found in
65 (87%) children [9].
The clinical relevance of detection of respiratory viruses such
as rhinovirus and coronavirus is a matter of debate. Rhinovirus
[23] and coronavirus [14] are well recognized as causes of the
common cold. On the other hand, there is increasing evidence
that they are also important causes of severe lower respiratory
disease. Rhinovirus infections have been reported in elderly
adults with LRTI or pneumonia [24,25] and in immunocompro-
mised patients [26,27]. Coronavirus infection has also been
reported in cases of LRTI [14,25,28,29]. Real-time PCR will
provide insight into the role played by such viruses in the aeti-
ology of LRTI.Available online http://ccforum.com/content/10/2/R61
Page 5 of 7
(page number not for citation purposes)
The high yield of PCR compared with conventional techniques
could theoretically be the result of contamination. However,
with using real-time PCR the likelihood of false-positive results
caused by carry-over contamination is reduced to a minimum.
This is achieved by the use of modified nucleotides (dUTP)
and uracil-DNA glycosylase (UNG) for control of contamina-
tion in the PCR-based amplification of (c)DNA as well as the
closed-tube detection system [3]. In addition, during the pro-
cedures of DNA/RNA isolation and amplification, several neg-
ative controls are included to monitor for possible false-
positive findings.
An additional advantage of real-time PCR over standard-for-
mat PCR is that it allows high-throughput screening of patient
samples for the presence of many different pathogens. Our
real-time PCR assays included testing not only for RSV, influ-
enzaviruses and PIVs, but also for rhinoviruses, adenoviruses,
the recently discovered hMPV [30], coronaviruses (OC43,
229E and the newly identified coronavirus NL63 [31]) and the
atypical pathogens Mycoplasma pneumoniae and Chlamydia
pneumoniae. Thus, real-time PCR allows for maximal detec-
tion of multiple viral and atypical infections in children with
LRTI, with a negligible risk for false-positive results.
In the PICU patients studied, we found a high prevalence of
multiple viral infections (35%), including triple and even quad-
ruple infections. In previous studies the detection of multiple
infections varied considerably, ranging from 0.6% to 27%. A
low prevalence was found in studies using PCR for RSV, influ-
enzaviruses and PIVs only [18,22]. In contrast, a high preva-
lence was found in studies that included a broad range of
respiratory viruses (including rhinovirus, adenovirus, coronavi-
rus and hMPV) [9]. Interestingly, in the latter study most coro-
naviruses were identified as part of multiple virus infections
(three out of four), which is in accordance with our findings.
The prevalence of possible or proven bacterial infection in our
study group was high (74%). The fact that almost half of the
children were diagnosed with a possible bacterial infection
indicates the difficulty of precluding this diagnosis. In addition,
previous studies showed that viral infection may pave the way
for bacterial infection [32]. The only study that compared viral
diagnostic methods in a similar population of PICU patients
did not report on the prevalence of bacterial infections, and so
we can not compare this finding with those from other studies
[16]. In contrast to the high prevalence of possible or proven
bacterial infection found in our study group, we did not dem-
onstrate infections with atypical pathogens such as Myco-
plasma pneumoniae and Chlamydia pneumoniae. It can be
speculated that atypical pathogens do not play an important
role in children with severe LRTI.
The small study group included in our study represents a limi-
tation; it did not allow us to find an association between clini-
cal characteristics and multiple infections. Furthermore, the
samples that were negative by conventional methods and pos-
itive by real-time PCR could not be confirmed using a true gold
standard because such a standard for respiratory viruses does
not exist. This is a problem encountered in all studies of respi-
ratory viruses.
The finding that real-time PCR increases the yield of viral diag-
noses for PICU patients with LRTI has implications for clinical
practice. The rapidity and sensitivity of real-time PCR test
results can help the clinician to initiate appropriate cohorting
strategies to prevent other critically ill children from nosoco-
mial viral infections. A reliable and rapid viral test result can
also be taken into account when prescribing or discontinuing
antibiotic treatment. Our study was not designed to determine
when antibiotic treatment for LRTI in the PICU is warranted.
The high percentage of possible or proven bacterial infections
in our viral LRTI patients indicates that antibiotic treatment
poses a dilemma in the PICU. The clinical impact of the high
prevalence of multiple virus infections detected in our PICU
remains unclear because they were not associated with differ-
ent clinical characteristics. Further research with larger num-
bers of patients and age-matched control groups is needed to
determine the real clinical impact of multiple infections and to
determine whether the use of real-time PCR prevents unnec-
essary antibiotic treatment. However, real-time PCR offers a
rapid, sensitive and highly reliable new technique that may
improve our understanding of the epidemiology of severe
LRTIs.
Conclusion
Real-time PCR for a broad range of respiratory viruses was
found to be highly sensitive in children with severe lower res-
piratory tract infection in the PICU. In addition, real-time PCR
increased the diagnostic yield of positive samples by twofold
compared with conventional methods (viral culture and DIF).
Whereas conventional methods identified no multiple infec-
tions, real-time PCR found the prevalence of multiple infec-
tions to be 35%. Because real-time PCR is a rapid and
sensitive technique, it is able to guide initial patient cohorting
strategies and therapy in the PICU.
Key messages
•  Real-time PCR for the detection of respiratory viruses is 
a sensitive and reliable method in PICU patients with 
LRTI, and it increases the diagnostic yield compared 
with conventional methods.
•  Real-time PCR allows detection of multiple viral infec-
tions (found in 35% of patients in this study) that are not 
identified using conventional methods.
•  The rapidity and sensitivity of real-time PCR test results 
can help the clinician to initiate appropriate cohorting 
strategies to prevent other critically ill children from 
acquiring nosocomial viral infections.Critical Care    Vol 10 No 2    van de Pol et al.
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